Medicaid Pharmaceutical Plan Resources

Concerns about access to health care in the early 1960s led to the establishment of Medicare, Medicaid and other state medical assistance programs. As a result, the National Pharmaceutical Council (NPC) turned a major portion of its attention to government policies relating to access to prescription drugs. NPC developed a substantial body of information concerning government and third-party programs and established relationships with health care officials at the federal and state levels. Among the resources NPC developed was the “Compilation on State Welfare Drug Programs,” first published in 1963. This annual publication would later become NPC’s “Pharmaceutical Benefits Under State Medical Assistance Programs,” often referred to as “the Compilation.”

The data used to create each edition of the Compilation were assembled from numerous sources. The Compilation incorporated information on each state pharmacy program from an annual NPC survey of state Medicaid program administrators and pharmacy consultants, statistics from the Centers for Medicare and Medicaid Services (CMS), and information from other Federal agencies and organizations.

Although the Compilation is considered an invaluable resource by many public officials and private analysts, NPC ceased publication in 2007, when the organization turned its direction to evidence-based medicine. Every edition of the Compilation is still available on NPC’s website.

Newsletter Volume

E.V.I.dently July 2014

NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S. Graff, PharmD, NPC Director of...
Blog Post

#TBT: Medicaid Expansion & Historical Data

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Newsletter Volume

E.V.I.dently June 2013

Message From NPCHappy Birthday to…Us! Celebrating 60 Years as a Leader in Health Policy ResearchBiopharmaceutical companies have made enormous...
Blog Post

Evidence, Coverage and Incentives: Challenges in Personalized Medicine

Personalized medicine is greatly changing the way medicine is practiced, as well as how drugs and biologics are developed. Today patients are...
Blog Post

#TBT: Medicaid Expansion & Historical Data

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

Evidence, Coverage and Incentives: Challenges in Personalized Medicine

Personalized medicine is greatly changing the way medicine is practiced, as well as how drugs and biologics are developed. Today patients are...

Research

Pharmaceutical Technology Assessment: Perspectives From Payers

The processes and evidence used in making pharmaceutical coverage decisions vary substantially...

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research

By choosing "winners and losers," CER drug trials may leave patients who best respond to the "...

The Impact of Comparative Effectiveness Research on Health and Health Care Spending

This research illustrates some of the issues that must be addressed in applying the results of...

  •  
  • 1 of 18
  • >